Pfizer-BioNTech is postponing its rolling application to the Food and Drug Administration (FDA) to expand the use of its two-dose COVID-19 vaccine for children ages 6 months to 4 years, NBC News reported on Friday.
The move means that vaccines for this age group will not be available in the coming weeks.
(Israel National News' North American desk is keeping you updated until the start of Shabbat in New York. The time posted automatically on all Israel National News articles, however, is Israeli time.)
Read more